诺沃北方公司任命火星首席执行官为观察员, 以扩大美国肥胖治疗的存在. Novo Nordisk appoints Mars CEO to board observer to expand U.S. obesity treatment presence.

新北方公司任命马斯首席执行官Poul Weihrauch成为董事会观察员. Novo Nordisk has appointed Poul Weihrauch, CEO of Mars, as a board observer. 公司在年度股东大会上宣布了这一举动, 包括选举其他高管加入董事会. The move, announced at the company's annual general meeting, includes electing other executives to the board. 这一任命反映了该公司在竞争激烈的美国肥胖治疗市场扩大其存在的努力. This appointment reflects the company's efforts to expand its presence in the competitive U.S. obesity treatment market.